Clinical Trial Update: Evaluation of the Safety and Performance of the NESS L300 Plus System [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and performance of the NESS L300 Plus System for foot drop and related lower-extremity weakness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Foot Drop
• Thigh Muscle Weakness
• Upper Motor Neuron Injury or Disease

Snippet

Sponsor: Bioness Inc | Conditions: Foot Drop, Thigh Muscles Weakness (Hamstrings or Quadriceps) | Phase 3 | Status: COMPLETED